FACT: an open-label randomized phase III study of fulvestrant and anastrozole in combination compared with anastrozole alone as first-line therapy for patients with receptor-positive postmenopausal breast cancer (Q83523415)
Jump to navigation
Jump to search
scientific article published on 27 February 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | FACT: an open-label randomized phase III study of fulvestrant and anastrozole in combination compared with anastrozole alone as first-line therapy for patients with receptor-positive postmenopausal breast cancer |
scientific article published on 27 February 2012 |
Statements
FACT: an open-label randomized phase III study of fulvestrant and anastrozole in combination compared with anastrozole alone as first-line therapy for patients with receptor-positive postmenopausal breast cancer (English)
Jonas Bergh
Per-Ebbe Jönsson
Elisabet Kerstin Lidbrink
Maureen Trudeau
Wolfgang Eiermann
Daniel Brattström
Fredrik Wiklund
Roger Henriksson
27 February 2012